Equities Analysts Lift Earnings Estimates for Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) – Research analysts at Piper Jaffray Companies increased their Q1 2020 earnings estimates for shares of Neurocrine Biosciences in a research note issued to investors on Monday, July 29th, according to Zacks Investment Research. Piper Jaffray Companies analyst D. Amsellem now expects that the company will earn $0.53 per share for the quarter, up from their previous forecast of $0.41. Piper Jaffray Companies has a “Overweight” rating and a $111.00 price target on the stock. Piper Jaffray Companies also issued estimates for Neurocrine Biosciences’ Q2 2020 earnings at $0.81 EPS, Q3 2020 earnings at $1.01 EPS, FY2022 earnings at $7.37 EPS and FY2023 earnings at $8.78 EPS.